M
Mark G. Kortepeter
Researcher at University of Nebraska Medical Center
Publications - 30
Citations - 5971
Mark G. Kortepeter is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Ebola virus & Biocontainment. The author has an hindex of 8, co-authored 27 publications receiving 3728 citations. Previous affiliations of Mark G. Kortepeter include University of California & University of Nebraska Omaha.
Papers
More filters
Journal ArticleDOI
Remdesivir for the Treatment of Covid-19 - Final Report.
John H. Beigel,Kay M. Tomashek,Lori E. Dodd,Aneesh K. Mehta,Barry S. Zingman,Andre C. Kalil,Elizabeth L. Hohmann,Helen Y. Chu,Annie Luetkemeyer,Susan Kline,Diego Lopez de Castilla,Robert W. Finberg,Kerry Dierberg,Victor F. Tapson,Lanny Hsieh,Thomas F. Patterson,Roger Paredes,Daniel A. Sweeney,William R. Short,Giota Touloumi,David Chien Lye,Norio Ohmagari,Myoung-don Oh,Guillermo M. Ruiz-Palacios,Thomas Benfield,Gerd Fätkenheuer,Mark G. Kortepeter,Robert L. Atmar,C. Buddy Creech,JD Lundgren,Abdel G. Babiker,Sarah Pett,James D. Neaton,Timothy Burgess,Tyler Bonnett,Michelle Green,Mat Makowski,Anu Osinusi,Seema U Nayak,H. Clifford Lane +39 more
TL;DR: The data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.
Journal ArticleDOI
Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement.
Philip W. Smith,Arthur O. Anderson,George W. Christopher,Theodore J. Cieslak,G J Devreede,Glen A Fosdick,Carl B Greiner,John M Hauser,Steven H. Hinrichs,Kermit D. Huebner,Peter C. Iwen,Dawn Jourdan,Mark G. Kortepeter,V Paul Landon,Patricia A. Lenaghan,Robert E Leopold,LeRoy A. Marklund,James W. Martin,Sharon Medcalf,Robert J Mussack,Randall H Neal,Bruce S. Ribner,Jonathan Y Richmond,Chuck Rogge,Leo A Daly,Gary A. Roselle,Mark E. Rupp,Anthony R. Sambol,Joann E Schaefer,John Sibley,Andrew J. Streifel,Susanna G Von Essen,Kelly L. Warfield +32 more
TL;DR: The consensus recommendations are presented to standardize the planning, design, construction, and operation of BPCUs as one element of the U.S. preparedness effort.
Journal ArticleDOI
New filovirus disease classification and nomenclature
Jens H. Kuhn,Takuya Adachi,Neill K. J. Adhikari,Jose R. Arribas,Ibrahima Elhadj Bah,Daniel G. Bausch,Nahid Bhadelia,Matthias Borchert,Arne Broch Brantsæter,David M. Brett-Major,Timothy Burgess,Daniel S. Chertow,Christopher G. Chute,Theodore J. Cieslak,Robert Colebunders,Ian Crozier,Richard T. Davey,Hilde De Clerck,Rafael Delgado,Laura Evans,Mosoka Fallah,William A. Fischer,Tom Fletcher,Robert A. Fowler,Thomas Grünewald,Andy Hall,Angela L. Hewlett,Andy I. M. Hoepelman,Catherine F Houlihan,Giuseppe Ippolito,Shevin T. Jacob,Michael Jacobs,Robert Jakob,Frederique Jacquerioz,Laurent Kaiser,Andre C. Kalil,Rashidatu F Kamara,Jimmy Kapetshi,Hans-Dieter Klenk,Gary P. Kobinger,Mark G. Kortepeter,Colleen S. Kraft,Thomas Kratz,Henry S Kyobe Bosa,Marta Lado,Francois Lamontagne,H Cliff Lane,Leslie Lobel,Julius J. Lutwama,G. Marshall Lyon,Moses Massaquoi,Thomas A Massaquoi,Aneesh K. Mehta,Vital Mondonge Makuma,Srinivas Murthy,Tonny Seikikongo Musoke,Jean-Jacques Muyembe-Tamfum,Phiona Nakyeyune,Carolina Nanclares,Miriam Nanyunja,Justus Nsio-Mbeta,Tim O'Dempsey,Janusz T. Paweska,Clarence J. Peters,Peter Piot,Christophe Rapp,Bertrand Renaud,Bruce S. Ribner,Pardis C. Sabeti,John S. Schieffelin,Werner Slenczka,Moses J Soka,Armand Sprecher,James E. Strong,Robert Swanepoel,Timothy M. Uyeki,Michel Van Herp,Pauline Vetter,David A. Wohl,Timo Wolf,Anja Wolz,Alie H. Wurie,Zabulon Yoti +82 more
TL;DR: The recent large outbreak of Ebola virus disease in Western Africa resulted in greatly increased accumulation of human genotypic, phenotypic and clinical data, and improved the understanding of the spectrum of clinical manifestations, so that the WHO disease classification of EVD underwent major revision.
Journal ArticleDOI
Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers.
Janice M. Rusnak,Mark G. Kortepeter,Robert J. Hawley,Arthur O. Anderson,Ellen F. Boudreau,Edward M. Eitzen +5 more
TL;DR: The data help to define the inherent risks of working with the specific agents of bioterrorism and support the idea that research with these agents should be restricted to laboratories with experience in handling highly hazardous agents and where appropriate safety training and precautions can be implemented.
Journal ArticleDOI
Marburg virus disease: A summary for clinicians.
TL;DR: A summary of countermeasures for Marburg virus disease focusing on pathogenesis, clinical features, and diagnostics is provided to give the busy clinician a head start in reviewing the literature if faced with a patient with Marburgirus disease.